Table 2 Serum and aqueous humor osmolarity
From: Preclinical assessment of intravitreal ramucirumab: in vitro and in vivo safety profile
Blood osmolarity | Aqueous humor osmolarity | |||||
|---|---|---|---|---|---|---|
Baseline | Follow-up | P value | Baseline | Follow-up | P value | |
C1–C4—24 h | 338.5 (270.0–358.0) | 337.0 (335.0–357.0) | 0.9999 | 300.0 (300.0–300.0) | 331.0 (320.0–342.0) | 0.9999 |
C5–C9—7 days | 331.0 (324.0–355.0) | 324.5 (324.0–325.0) | 0.1797 | 332.0 (319.0–339.0) | 315.5 (246.0–329.0) | 0.0679 |
C9–C11—24 h | 307.5 (281–334.0) | 309.0 (260.0–322.0) | 0.1797 | 319.0 (212.0–323.0) | 331.0 (323.0–381.0) | 0.1088 |
C12–C16—7 days | NA | NA | NA | 323.0 (309.0–338.0) | 316.0 (305.0–435.0) | 0.9999 |